| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| MIR34A |
|
microRNA 34a
|
|
|
0.421 |
0.846 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
| MIR200B |
|
microRNA 200b
|
|
|
0.500 |
0.769 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| MIR33A |
|
microRNA 33a
|
|
|
0.560 |
0.654 |
| RPL17-C18orf32 |
|
RPL17-C18orf32 readthrough
|
|
0.58 |
0.572 |
0.615 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| WG |
|
Wegener granulomatosis
|
|
|
0.595 |
0.808 |
| H3C9P |
|
H3 clustered histone 9, pseudogene
|
|
|
0.656 |
0.538 |
| ERVK-11 |
|
endogenous retrovirus group K member 11
|
|
|
0.663 |
0.423 |
| H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
| ERVK-2 |
|
endogenous retrovirus group K member 2
|
|
|
0.674 |
0.423 |
| ERVK-12 |
|
endogenous retrovirus group K member 12
|
|
|
0.678 |
0.423 |
| ERVK-22 |
|
endogenous retrovirus group K member 22
|
|
|
0.678 |
0.423 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
| ESAT |
|
esterase activator
|
|
|
0.716 |
0.308 |
| ZSCAN16-AS1 |
|
ZSCAN16 antisense RNA 1
|
|
|
0.792 |
0.269 |